Company · CIK 0001631574 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Wave Life Sciences, Inc. · WVE
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 SForm 4 → | Aug 13, 9:00 pm EDT | Adrian RawcliffeDirector | 12,700 | $5.29 | $67,183 | 0 | −100% | 10b5-1 |
| Aug 11, 2026 SForm 4 → | Aug 13, 9:00 pm EDT | Heidi L WagnerDirector | 7,000 | $6.01 | $42,070 | 44,930 | −13.5% | 10b5-1 |
| Aug 11, 2026 MForm 4 → | Aug 13, 9:00 pm EDT | Heidi L WagnerDirector | 7,000 | $5.97 | $41,790 | 51,930 | — | 10b5-1 |
| Aug 11, 2026 SForm 4 → | Aug 13, 9:00 pm EDT | Ken TakanashiDirector | 3,864 | $6.01 | $23,223 | 20,079 | −16.1% | 10b5-1 |
| Aug 11, 2026 SForm 4 → | Aug 13, 9:00 pm EDT | Tan Aik NaDirector | 432 | $6.01 | $2,596 | 24,968 | −1.70% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2026 MForm 4 → | Aug 13, 9:00 pm EDT | Heidi L WagnerDirector | 7,000 | — | — | 0 | — | 10b5-1 |